UniProt ID | P73_HUMAN | |
---|---|---|
UniProt AC | O15350 | |
Protein Name | Tumor protein p73 | |
Gene Name | TP73 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 636 | |
Subcellular Localization | Nucleus . Cytoplasm. Accumulates in the nucleus in response to DNA damage. | |
Protein Description | Participates in the apoptotic response to DNA damage. Isoforms containing the transactivation domain are pro-apoptotic, isoforms lacking the domain are anti-apoptotic and block the function of p53 and transactivating p73 isoforms. May be a tumor suppressor protein.. | |
Protein Sequence | MAQSTATSPDGGTTFEHLWSSLEPDSTYFDLPQSSRGNNEVVGGTDSSMDVFHLEGMTTSVMAQFNLLSSTMDQMSSRAASASPYTPEHAASVPTHSPYAQPSSTFDTMSPAPVIPSNTDYPGPHHFEVTFQQSSTAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREQQALNESSAKNGAASKRAFKQSPPAVPALGAGVKKRRHGDEDTYYLQVRGRENFEILMKLKESLELMELVPQPLVDSYRQQQQLLQRPSHLQPPSYGPVLSPMNKVHGGMNKLPSVNQLVGQPPPHSSAATPNLGPVGPGMLNNHGHAVPANGEMSSSHSAQSMVSGSHCTPPPPYHADPSLVSFLTGLGCPNCIEYFTSQGLQSIYHLQNLTIEDLGALKIPEQYRMTIWRGLQDLKQGHDYSTAQQLLRSSNAATISIGGSGELQRQRVMEAVHFRVRHTITIPNRGGPGGGPDEWADFGFDLPDCKARKQPIKEEFTEAEIH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MAQSTATSPDG ----CCCCCCCCCCC | 15.52 | 28348404 | |
5 | Phosphorylation | ---MAQSTATSPDGG ---CCCCCCCCCCCC | 23.13 | 28348404 | |
7 | Phosphorylation | -MAQSTATSPDGGTT -CCCCCCCCCCCCCC | 40.66 | 28348404 | |
8 | Phosphorylation | MAQSTATSPDGGTTF CCCCCCCCCCCCCCH | 20.66 | 28348404 | |
13 (in isoform 10) | Phosphorylation | - | 33.56 | - | |
13 (in isoform 12) | Phosphorylation | - | 33.56 | - | |
13 (in isoform 9) | Phosphorylation | - | 33.56 | - | |
13 (in isoform 8) | Phosphorylation | - | 33.56 | - | |
27 | Phosphorylation | SSLEPDSTYFDLPQS HHCCCCCCEECCCCC | 35.27 | 18418051 | |
28 | Phosphorylation | SLEPDSTYFDLPQSS HCCCCCCEECCCCCC | 10.07 | 22817900 | |
47 | Phosphorylation | EVVGGTDSSMDVFHL CCCCCCCCCCEEEEC | 27.66 | 14585975 | |
48 | Phosphorylation | VVGGTDSSMDVFHLE CCCCCCCCCEEEECC | 23.08 | - | |
86 | Phosphorylation | AASASPYTPEHAASV HHHCCCCCHHHHCCC | 26.11 | 12676926 | |
99 | Phosphorylation | SVPTHSPYAQPSSTF CCCCCCCCCCCCCCC | 22.38 | 10381648 | |
145 | Phosphorylation | KSATWTYSPLLKKLY CCCCEECHHHHHHHH | 11.16 | 24719451 | |
152 | Phosphorylation | SPLLKKLYCQIAKTC HHHHHHHHHHHHCCC | 7.38 | 29496907 | |
166 | Phosphorylation | CPIQIKVSTPPPPGT CCEEEEECCCCCCCC | 30.14 | 27080861 | |
167 | Phosphorylation | PIQIKVSTPPPPGTA CEEEEECCCCCCCCE | 42.68 | 27067055 | |
173 | Phosphorylation | STPPPPGTAIRAMPV CCCCCCCCEEEEEEC | 25.37 | - | |
181 | Phosphorylation | AIRAMPVYKKAEHVT EEEEEECCCCCHHHH | 10.82 | 20873877 | |
223 | Phosphorylation | RVEGNNLSQYVDDPV EEECCCHHHHCCCCC | 22.91 | 28787133 | |
225 | Phosphorylation | EGNNLSQYVDDPVTG ECCCHHHHCCCCCCC | 11.50 | 28787133 | |
235 | Phosphorylation | DPVTGRQSVVVPYEP CCCCCCEEEEECCCC | 18.60 | 22340593 | |
289 | Phosphorylation | GQVLGRRSFEGRICA CEEECCCCCCCCEEC | 26.70 | - | |
296 (in isoform 9) | Ubiquitination | - | 10.52 | 21906983 | |
296 (in isoform 8) | Ubiquitination | - | 10.52 | 21906983 | |
296 (in isoform 10) | Ubiquitination | - | 10.52 | 21906983 | |
321 | Acetylation | ALNESSAKNGAASKR HHHHHHHHHCHHHHH | 58.84 | 20167786 | |
321 | Neddylation | ALNESSAKNGAASKR HHHHHHHHHCHHHHH | 58.84 | - | |
326 | Phosphorylation | SAKNGAASKRAFKQS HHHHCHHHHHHHHHC | 23.34 | 24260401 | |
327 | Neddylation | AKNGAASKRAFKQSP HHHCHHHHHHHHHCC | 42.91 | - | |
327 | Acetylation | AKNGAASKRAFKQSP HHHCHHHHHHHHHCC | 42.91 | 20167786 | |
331 | Neddylation | AASKRAFKQSPPAVP HHHHHHHHHCCCCHH | 49.21 | - | |
331 | Acetylation | AASKRAFKQSPPAVP HHHHHHHHHCCCCHH | 49.21 | 11804596 | |
333 | Phosphorylation | SKRAFKQSPPAVPAL HHHHHHHCCCCHHCC | 33.18 | 25056879 | |
345 | Ubiquitination | PALGAGVKKRRHGDE HCCCCCCCCCCCCCC | 39.38 | - | |
345 | Ubiquitination | PALGAGVKKRRHGDE HCCCCCCCCCCCCCC | 39.38 | 2190698 | |
345 (in isoform 1) | Ubiquitination | - | 39.38 | 21906983 | |
345 (in isoform 2) | Ubiquitination | - | 39.38 | 21906983 | |
345 (in isoform 3) | Ubiquitination | - | 39.38 | 21906983 | |
345 (in isoform 4) | Ubiquitination | - | 39.38 | 21906983 | |
345 (in isoform 5) | Ubiquitination | - | 39.38 | 21906983 | |
345 (in isoform 6) | Ubiquitination | - | 39.38 | 21906983 | |
388 | Phosphorylation | VPQPLVDSYRQQQQL CCHHHHHHHHHHHHH | 18.09 | 22817900 | |
412 | Phosphorylation | PSYGPVLSPMNKVHG CCCCCCCCCCCHHCC | 23.49 | 29978859 | |
426 | Phosphorylation | GGMNKLPSVNQLVGQ CCCCCCCCHHHHCCC | 44.10 | - | |
471 | Phosphorylation | GEMSSSHSAQSMVSG CCCCCCCCCCHHHCC | 29.92 | 21482671 | |
568 | Phosphorylation | LRSSNAATISIGGSG HHCCCCCEEEECCCH | 16.91 | - | |
627 | Sumoylation | KARKQPIKEEFTEAE HHCCCCCHHHHHHCC | 58.85 | 15572666 | |
627 | Sumoylation | KARKQPIKEEFTEAE HHCCCCCHHHHHHCC | 58.85 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
27 | T | Phosphorylation | Kinase | CK2A2 | P19784 | PSP |
27 | T | Phosphorylation | Kinase | PLK1 | P53350 | Uniprot |
28 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
28 | Y | Phosphorylation | Kinase | HCK | P08631 | Uniprot |
47 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
48 | S | Phosphorylation | Kinase | PLK2 | Q9NYY3 | PSP |
86 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
86 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
99 | Y | Phosphorylation | Kinase | ABL | P00519 | PSP |
99 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
235 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
289 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
289 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
388 | S | Phosphorylation | Kinase | PRKCB | P05771-2 | GPS |
388 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
426 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
471 | S | Phosphorylation | Kinase | IKKB | O14920 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | RCHY1 | Q96PM5 | PMID:21994467 |
- | K | Ubiquitination | E3 ubiquitin ligase | DDB1 | Q16531 | PMID:23085759 |
- | K | Ubiquitination | E3 ubiquitin ligase | MDM2 | Q00987 | PMID:26025930 |
- | K | Ubiquitination | E3 ubiquitin ligase | MUL1 | Q969V5 | PMID:26435500 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXO45 | P0C2W1 | PMID:19581926 |
- | K | Ubiquitination | E3 ubiquitin ligase | ITCH | Q96J02 | PMID:15678106 |
- | K | Ubiquitination | E3 ubiquitin ligase | HECW2 | Q9P2P5 | PMID:12890487 |
- | K | Ubiquitination | E3 ubiquitin ligase | WWP2 | O00308 | PMID:25071155 |
- | K | Ubiquitination | E3 ubiquitin ligase | WWP1#WWP2 | Q9H0M0#O00308 | PMID:25071155 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
627 | K | Sumoylation |
| 10961991 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of P73_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Inhibitory role of Plk1 in the regulation of p73-dependent apoptosisthrough physical interaction and phosphorylation."; Koida N., Ozaki T., Yamamoto H., Ono S., Koda T., Ando K., Okoshi R.,Kamijo T., Omura K., Nakagawara A.; J. Biol. Chem. 283:8555-8563(2008). Cited for: FUNCTION, PHOSPHORYLATION AT THR-27, AND MUTAGENESIS OF THR-27. | |
"p73-mediated transcriptional activity is negatively regulated bypolo-like kinase 1."; Soond S.M., Barry S.P., Melino G., Knight R.A., Latchman D.S.,Stephanou A.; Cell Cycle 7:1214-1223(2008). Cited for: PHOSPHORYLATION AT THR-27. | |
"Regulation of p73 by Hck through kinase-dependent and independentmechanisms."; Paliwal P., Radha V., Swarup G.; BMC Mol. Biol. 8:45-45(2007). Cited for: PHOSPHORYLATION AT TYR-28, SUBCELLULAR LOCATION, AND INTERACTION WITHHCK. | |
"p73 is regulated by tyrosine kinase c-Abl in the apoptotic responseto DNA damage."; Yuan Z.-M., Shioya H., Ishiko T., Sun X., Gu J., Huang Y., Lu H.,Kharbanda S., Weichselbaum R., Kufe D.; Nature 399:814-817(1999). Cited for: INTERACTION WITH ABL1, PHOSPHORYLATION AT TYR-99 BY ABL1, ANDMUTAGENESIS OF TYR-99. | |
Sumoylation | |
Reference | PubMed |
"Covalent modification of p73alpha by SUMO-1. Two-hybrid screeningwith p73 identifies novel SUMO-1-interacting proteins and a SUMO-1interaction motif."; Minty A., Dumont X., Kaghad M., Caput D.; J. Biol. Chem. 275:36316-36323(2000). Cited for: SUMOYLATION AT LYS-627, AND MUTAGENESIS OF LYS-627. |